CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $718,000 | +5.6% | 30,200 | 0.0% | 0.03% | +29.2% |
Q1 2022 | $680,000 | +13.7% | 30,200 | 0.0% | 0.02% | +26.3% |
Q4 2021 | $598,000 | -49.7% | 30,200 | -50.0% | 0.02% | -20.8% |
Q3 2021 | $1,188,000 | +78.9% | 60,400 | +100.0% | 0.02% | -4.0% |
Q2 2021 | $664,000 | -7.5% | 30,200 | 0.0% | 0.02% | -13.8% |
Q1 2021 | $718,000 | -9.1% | 30,200 | 0.0% | 0.03% | -21.6% |
Q4 2020 | $790,000 | +41.1% | 30,200 | -6.2% | 0.04% | +27.6% |
Q3 2020 | $560,000 | +10.9% | 32,200 | 0.0% | 0.03% | +7.4% |
Q2 2020 | $505,000 | +31.9% | 32,200 | 0.0% | 0.03% | +3.8% |
Q1 2020 | $383,000 | -1.8% | 32,200 | 0.0% | 0.03% | +23.8% |
Q4 2019 | $390,000 | -22.9% | 32,200 | -10.1% | 0.02% | -27.6% |
Q3 2019 | $506,000 | +26.8% | 35,800 | 0.0% | 0.03% | +26.1% |
Q2 2019 | $399,000 | -5.0% | 35,800 | 0.0% | 0.02% | -8.0% |
Q1 2019 | $420,000 | -12.1% | 35,800 | 0.0% | 0.02% | -24.2% |
Q4 2018 | $478,000 | -4.8% | 35,800 | 0.0% | 0.03% | +13.8% |
Q3 2018 | $502,000 | -10.8% | 35,800 | 0.0% | 0.03% | -17.1% |
Q2 2018 | $563,000 | -4.4% | 35,800 | 0.0% | 0.04% | -7.9% |
Q1 2018 | $589,000 | -9.0% | 35,800 | 0.0% | 0.04% | -7.3% |
Q4 2017 | $647,000 | -16.2% | 35,800 | -10.5% | 0.04% | -21.2% |
Q3 2017 | $772,000 | +63.6% | 40,000 | 0.0% | 0.05% | +57.6% |
Q2 2017 | $472,000 | +7.8% | 40,000 | 0.0% | 0.03% | +13.8% |
Q1 2017 | $438,000 | +51.0% | 40,000 | 0.0% | 0.03% | +45.0% |
Q4 2016 | $290,000 | +11.5% | 40,000 | 0.0% | 0.02% | +5.3% |
Q3 2016 | $260,000 | +19.3% | 40,000 | 0.0% | 0.02% | +11.8% |
Q2 2016 | $218,000 | +16.6% | 40,000 | 0.0% | 0.02% | +13.3% |
Q1 2016 | $187,000 | -6.0% | 40,000 | 0.0% | 0.02% | -6.2% |
Q4 2015 | $199,000 | +32.7% | 40,000 | 0.0% | 0.02% | +23.1% |
Q3 2015 | $150,000 | -37.5% | 40,000 | 0.0% | 0.01% | -35.0% |
Q2 2015 | $240,000 | -14.3% | 40,000 | -20.0% | 0.02% | -16.7% |
Q1 2015 | $280,000 | +86.7% | 50,000 | 0.0% | 0.02% | +84.6% |
Q4 2014 | $150,000 | +11.9% | 50,000 | 0.0% | 0.01% | +8.3% |
Q3 2014 | $134,000 | -4.3% | 50,000 | 0.0% | 0.01% | 0.0% |
Q2 2014 | $140,000 | -35.8% | 50,000 | 0.0% | 0.01% | -40.0% |
Q1 2014 | $218,000 | +35.4% | 50,000 | 0.0% | 0.02% | +33.3% |
Q4 2013 | $161,000 | +101.2% | 50,000 | 0.0% | 0.02% | +87.5% |
Q3 2013 | $80,000 | -8.0% | 50,000 | 0.0% | 0.01% | -11.1% |
Q2 2013 | $87,000 | – | 50,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |